AIM ImmunoTech Inc. (LON:0A4Y)
0.8215
-0.1735 (-17.44%)
At close: Feb 11, 2026
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of 1.77 million as of February 12, 2026. Its market cap has decreased by -82.89% in one year.
Market Cap
1.77M
Enterprise Value
1.71M
Revenue
83.32K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.82
Market Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from 26.31M to 1.77M, a decrease of -93.29%. That is a compound annual growth rate of -8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.77M | -26.28% |
| Dec 31, 2025 | 2.40M | -76.25% |
| Dec 31, 2024 | 10.09M | -40.20% |
| Dec 29, 2023 | 16.87M | 35.52% |
| Dec 30, 2022 | 12.45M | -61.71% |
| Dec 31, 2021 | 32.51M | -39.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BSF Enterprise | 2.31M |
| Beacon Rise Holdings | 2.26M |
| Anemoi International | 2.12M |
| Chesterfield Resources | 1.97M |
| Wildcat Petroleum | 1.95M |
| Roquefort Therapeutics | 1.80M |
| Boston International Holdings | 1.58M |
| R8 Capital Investments | 1.52M |